The differential role of androgens in early human sex development

BMC Medicine

Volumn 11, Issue 1, 2013, Pages

  Hiort, Olaf ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Androgen insensitivity; Androgen receptor; Androgens; Disorders of sex development; Genetics; Sex development

Indexed keywords

3ALPHA HYDROXYSTEROID DEHYDROGENASE; ANDROGEN; ANDROGEN RECEPTOR; HEAT SHOCK PROTEIN; SEX HORMONE; TESTOSTERONE 17BETA DEHYDROGENASE; TRANSCRIPTION FACTOR;

ANDROGEN SYNTHESIS; BODY COMPOSITION; CELL DIFFERENTIATION; CLITORIS; DNA TRANSCRIPTION; FEMINIZATION; GENE TARGETING; GENETIC REGULATION; GENITAL SYSTEM; GONAD DEVELOPMENT; HORMONE ACTION; HORMONE DEFICIENCY; HORMONE RESPONSIVE ELEMENT; HUMAN; METABOLITE; NONHUMAN; NUCLEAR REPROGRAMMING; PENIS; PHENOTYPE; POSTNATAL DEVELOPMENT; PRENATAL DEVELOPMENT; REVIEW; SCROTUM; SEX DIFFERENCE; SEXUAL DEVELOPMENT; TIME; URETHRA; VIRILIZATION; X CHROMOSOME; Y CHROMOSOME;

ANDROGENS; ANIMALS; CELL DIFFERENTIATION; DISORDERS OF SEX DEVELOPMENT; FEMALE; HUMANS; MALE; SEX DIFFERENTIATION; SEXUAL DEVELOPMENT;

EID: 84879213254     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-11-152     Document Type: Review

References (41)

1. Sekido R, Lovell-Badge R. Sex determination involves synergistic action of SRY and SF1 on a specific Sox9 enhancer. Nature 2008, 453:930-934. 10.1038/nature06944, 18454134.
2. Arnold AP. The end of gonad-centric sex determination in mammals. Trends Genet 2012, 28:55-61. 10.1016/j.tig.2011.10.004, 3268825, 22078126.
3. DeFalco T, Capel B. Gonad morphogenesis in vertebrates: divergent means to a convergent end. Annu Rev Cell Dev Biol 2009, 25:457-482. 10.1146/annurev.cellbio.042308.13350, 19807280.
4. Bashamboo A, McElreavey K. Gene mutations associated with anomalies of human gonad formation. Sex Dev 2013, 7:126-146. 10.1159/000342188, 23037587.
5. Yamada G, Suzuki K, Haraguchi R, Miyagawa S, Satoh Y, Kamimura M, Nakagata N, Kataoka H, Kuroiwa A, Chen Y. Molecular genetic cascades for external genitalia formation: an emerging organogenesis program. Dev Dyn 2006, 235:1738-1735. 10.1002/dvdy.20807, 16598715.
6. Miyagawa S, Satoh Y, Haraguchi R, Suzuki K, Iguchi T, Taketo MM, Nakagata N, Matsumoto T, Takeyama K, Kato S, Yamada G. Genetic interactions of the androgen and Wnt/beta-catenin pathways for the masculinization of external genitalia. Mol Endocrinol 2009, 23:871-880. 10.1210/me.2008-0478, 2725765, 19282366.
7. Welsh M, Saunders PT, Fisken M, Scott HM, Hutchison GR, Smith LB, Sharpe RM. Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism. J Clin Invest 2008, 118:1479-1490. 10.1172/JCI34241, 2267017, 18340380.
8. Hiort O. Clinical and molecular aspects of androgen insensitivity. Endocr Dev 2013, 24:33-40.
9. Werner R, Grötsch H, Hiort O. 46, XY disorders of sex development-the undermasculinised male with disorders of androgen action. Best Pract Res Clin Endocrinol Metab 2010, 24:263-277. 10.1016/j.beem.2009.11.002, 20541151.
10. Papadimitriou DT, Linglart A, Morel Y, Chaussain JL. Puberty in subjects with complete androgen insensitivity syndrome. Horm Res 2006, 65:126-131. 10.1159/000091592, 16491011.
11. Bouvattier C, Carel JC, Lecointre C, David A, Sultan C, Bertrand AM, Morel Y, Chaussain JL. Postnatal changes of T, LH, and FSH in 46, XY infants with mutations in the AR gene. J Clin Endocrinol Metab 2002, 87:29-32. 10.1210/jc.87.1.29, 11788616.
12. Kamrath C, Hartmann MF, Wudy SA. Androgen synthesis in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Horm Metab Res 2013, 45:86-91.
13. Flück CE, Meyer-Böni M, Pandey AV, Kempná P, Miller WL, Schoenle EJ, Biason-Lauber A. Why boys will be boys: two pathways of fetal testicular androgen biosynthesis are needed for male sexual differentiation Erratum in. Am J Hum Genet 2011, 89:347.
14. Kamrath C, Hochberg Z, Hartmann MF, Remer T, Wudy SA. Increased activation of the alternative "backdoor" pathway in patients with 21-hydroxylase deficiency: evidence from urinary steroid hormone analysis. J Clin Endocrinol Metab 2012, 97:E367-E375. 10.1210/jc.2011-1997, 22170725.
15. Biason-Lauber A, Miller WL, Pandey AV, Flück CE. Of marsupials and men: "backdoor" dihydrotestosterone synthesis in male sexual differentiation. Mol Cell Endocrinol 2013, 371:124-132. 10.1016/j.mce.2013.01.017, 23376007.
16. Berenbaum SA, Beltz AM. Sexual differentiation of human behavior: effects of prenatal and pubertal organizational hormones. Front Neuroendocrinol 2011, 32:183-200. 10.1016/j.yfrne.2011.03.001, 21397624.
17. De Zegher FI, Boehmer ALM, Saggese G, Müller J, Hiort O, Sultan C, Clayton P, Brauner R, Cacciari E, Ibanez L, van Vliet G, Tiulpakov A, Saka N, Ritzen M, Sippell WG. Androgens and fetal growth. Horm Res 1998, 50:243-244. 10.1159/000023284, 9838248.
18. Jurgensen M, Hiort O, Holterhus PM, Thyen U. Gender role behavior in children with XY karyotype and disorders of sex development. Horm Behav 2007, 51:443-453. 10.1016/j.yhbeh.2007.01.001, 17306800.
19. Han TS, Goswami D, Trikudanathan S, Creighton SM, Conway GS. Comparison of bone mineral density and body proportions between women with complete androgen insensitivity syndrome and women with gonadal dysgenesis. Eur J Endocrinol 2008, 159:179-185. 10.1530/EJE-08-0166, 18463105.
20. Maimoun L, Philibert P, Cammas B, Audran F, Bouchard P, Fenichel P, Cartigny M, Pienkowski C, Polak M, Skordis N, Mazen I, Ocal G, Berberoglu M, Reynaud R, Baumann C, Cabrol S, Simon D, Kayemba-Kay's K, De Kerdanet M, Kurtz F, Leheup B, Heinrichs C, Tenoutasse S, Van Vliet G, Grüters A, Eunice M, Ammini AC, Hafez M, Hochberg Z, Einaudi S, et al. Phenotypical, biological, and molecular heterogeneity of 5α-reductase deficiency: an extensive international experience of 55 patients. J Clin Endocrinol Metab 2011, 96:296-307. 10.1210/jc.2010-1024, 21147889.
21. Ngun TC, Ghahramani N, Sánchez FJ, Bocklandt S, Vilain E. The genetics of sex differences in brain and behavior. Front Neuroendocrinol 2011, 32:227-246. 10.1016/j.yfrne.2010.10.001, 3030621, 20951723.
22. Hochberg Z. Evo-devo of child growth II: human life history and transition between its phases. Eur J Endocrinol 2009, 160:135-141.
23. Hiort O. Androgens and puberty. Best Pract Res Clin Endocrinol Metab 2002, 16:31-41. 10.1053/beem.2002.0178, 11987896.
24. Deslypere JP, Young M, Wilson JD, McPhaul MJ. Testosterone and 5 alpha-dihydrotestosterone interact differently with the androgen receptor to enhance transcription of the MMTV-CAT reporter gene. Mol Cell Endocrinol 1992, 88:15-22. 10.1016/0303-7207(92)90004-P, 1334007.
25. Holterhus PM, Piefke S, Hiort O. Anabolic steroids, testosterone-precursors and virilizing androgens induce distinct activation profiles of androgen responsive promoter constructs. J Steroid Biochem Molec Biol 2002, 82:269-275. 10.1016/S0960-0760(02)00220-0, 12589933.
26. Hellwinkel OJC, Müller A, Struve D, Hiort O. Influence of androgens and age on androgen receptor and 5α-reductase II transcription. Eur J Endocrinol 2000, 143:217-225. 10.1530/eje.0.1430217, 10913941.
27. Hellwinkel OJC, Bassler J, Hiort O. Transkription of androgen receptor and 5α-reductase II in genital skin fibroblasts from patients with androgen insensitivity syndrome. J Steroid Biochem Molec Biol 2000, 75:213-218. 10.1016/S0960-0760(00)00174-6, 11282274.
28. Thiele S, Hoppe U, Holterhus PM, Hiort O. Isoenzyme type 1 of 5α-reductase is abundantly transcribed in normal human genital skin fibroblasts and may play an important role in masculinization of 5α-reductase type 2 deficient males. Eur J Endocrinol 2005, 152:875-880. 10.1530/eje.1.01927, 15941927.
29. Hoppe U, Holterhus PM, Wünsch L, Jocham D, Drechsler T, Thiele S, Marschke C, Hiort O. Tissue-specific transcription profiles of sex steroid biosynthesis enzymes and the androgen receptor. J Mol Med 2006, 84:651-659. 10.1007/s00109-006-0049-1, 16572348.
30. Hoppe U, Wünsch L, Holterhus PM, Jocham D, Richter-Unruh A, Hiort O. Altered transcription profiles of key-enzymes of androgen biosynthesis in genital skin fibroblasts from patients with 46, XY disorders of sex development. Sex Dev 2007, 1:230-237. 10.1159/000104773, 18391534.
31. Werner R, Kulle A, Sommerfeld I, Riepe FG, Wudy S, Hartmann MF, Merz H, Döhnert U, Bertelloni S, Holterhus PM, Hiort O. Testosterone synthesis in patients with 17β-hydroxysteroid dehydrogenase 3 deficiency. Sex Dev 2012, 6:161-168. 10.1159/000336605, 22398356.
32. Jenster G, Trapman J, Brinkmann AO. Nuclear import of the human androgen receptor. Biochem J 1993, 293:761-768. 1134432, 8352744.
33. Shaffer PL, Jivan A, Dollins DE, Claessens F, Gewirth DT. Structural basis of androgen receptor binding to selective androgen response elements. Proc Natl Acad Sci U S 2004, 101:4758-4763.
34. Lonard DM, Lanz RB, O'Malley BW. Nuclear receptor coregulators and human disease. Endocr Rev 2007, 28:575-587. 10.1210/er.2007-0012, 17609497.
35. Lonard DM, O'Malley BW. Nuclear receptor coregulators: judges, juries, and executioners of cellular regulation. Mol Cell 2007, 27:691-700. 10.1016/j.molcel.2007.08.012, 17803935.
36. Bebermeier JH, Brooks J, DePrimo S, Werner R, Deppe U, Demeter J, Hiort O, Holterhus PM. Cell-line and tissue specific signatures of androgen receptor coregulator transcription. J Mol Med 2006, 84:919-931. 10.1007/s00109-006-0081-1, 16932916.
37. Holterhus PM, Hiort O, Demeter J, Brown PO, Brooks JD. Differential gene expression patterns in genital fibroblasts of normal and 46, XY-females with androgen insensitivity syndrome: evidence for early programming involving the androgen receptor. Genome Biol 2003, 4:R37. 10.1186/gb-2003-4-6-r37, 193616, 12801411.
38. Holterhus PM, Deppe U, Werner R, Richter-Unruh A, Bebermeier JH, Wunsch L, Krege S, Schweikert HU, Demeter J, Riepe F, Hiort O, Brooks JD. Intrinsic androgen-dependent gene expression patterns revealed by comparison of genital fibroblasts from normal males and individuals with complete and partial androgen insensitivity syndrome. BMC Genomics 2007, 18:376.
39. Appari M, Werner R, Wünsch L, Cario G, Demeter J, Hiort O, Riepe F, Brooks JD, Holterhus PM. Apolipoprotein D (APOD) is a putative biomarker of androgen receptor function in androgen insensitivity syndrome. J Mol Med 2009, 87:623-632. 10.1007/s00109-009-0462-3, 19330472.
40. Holterhus PM, Bebermeier JH, Werner R, Demeter J, Richter-Unruh A, Cario G, Appari M, Siebert R, Riepe F, Brooks JD, Hiort O. Disorders of sex development expose transcriptional autonomy of genetic sex and androgen-programmed hormonal sex in human blood leukocytes. BMC Genomics 2009, 10:292. 10.1186/1471-2164-10-292, 2713997, 19570224.
41. Bens S, Ammerpohl O, Martin-Subero JI, Appari M, Richter J, Hiort O, Werner R, Riepe FG, Siebert R, Holterhus PM. Androgen receptor mutations are associated with altered epigenomic programming as evidenced by HOXA5 methylation. Sex Dev 2011, 5:70-76. 10.1159/000323807, 21311178.